India, Oct. 21 -- Danaher Corp. (DHR), a science and technology company, announced Monday that it has signed an agreement to sell certain of its businesses in the Life Sciences segment to Sartorius AG for approximately $750 million.
Danaher said the planned sale is a step towards obtaining regulatory approval for its pending acquisition of the GE Biopharma business. The closing of the Sartorius AG agreement is conditioned upon Danaher's closing its acquisition of the GE Biopharma business.
The divesting businesses include label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses. The combined revenue of the businesses was approximately $140 million in 2018....